AB Active ETFs Inc - AB Corporate Bond ETF
EYEG
Market Cap$26.72M
Close$
$0.11
99.7% downside
Current Fair Value
99.7% downsideOvervalued by 99.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $26.72 Million |
|---|---|
| Enterprise Value | $24.05 Million |
| Dividend Yield | $2.103 (5.92855290310213%) |
| Earnings per Share | $1.99 |
| Beta | 0.23 |
| Outstanding Shares | 4,217,007 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 17.6 |
|---|---|
| PEG | -67.48 |
| Price to Sales | 11.82 |
| Price to Book Ratio | 7.09 |
| Enterprise Value to Revenue | 1.5 |
| Enterprise Value to EBIT | 4.17 |
| Enterprise Value to Net Income | 2 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Eyegate Pharmaceuticals Inc
CEO: Stephen From